Screener
Nutex Health Inc. NUTX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 51.3%-0.1pp | 47.5%-1.3pp | 50.8%+9.9pp | 55%+31.8pp | 51.4%+32.1pp | |
| Operating margin | 43%+13.0pp | 31.4%-2.2pp | 31.5%+4.3pp | 36.6%+39.9pp | 30.1%+37.4pp | |
| Net margin | 21.2%+14.1pp | 11%-0.9pp | 8.1%-2.8pp | 12.3%+26.4pp | 7.1%+20.9pp | |
| Returns | ||||||
| Return on equity | 57.2%+19.3pp | 35.5%-21.2pp | 30.7%-23.2pp | 63.9%+119pp | 37.9%+86.7pp | |
| Return on invested capital | 57.2%+8.9pp | 45.6%+0.3pp | 44%+13.4pp | 70.7%+73.5pp | 48.3%+54.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×-0.3× | 1×0.0× | 1.1×+0.2× | 1.4×+0.8× | 1.3×+0.6× | |
| Liquidity | ||||||
| Current ratio | 5×+2.6× | 3.1×+0.9× | 3.4×+1.5× | 3.2×+1.4× | 2.4×+0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-0.6× | 1×-0.7× | 1.1×-1.5× | 1.1×-3.8× | 1.4×-3.1× | |
| Net debt / EBITDA | 0.4×-0.6× | 0.5×-0.6× | 0.6×-1.4× | 0.5×-28.8× | 0.9×— | |
| Valuation | ||||||
| Market capitalization | $1.05B+101% | $662.27M+159% | $1.16B+576% | $573.95M+422% | $640.73M+2,066% | |
| Price / earnings | 5.8×-3.4× | 6.9×+3.4× | 16.4×+13.1× | 4.8×— | 11.4×— | |
| Price / sales | 1.2×+0.6× | 0.8×+0.3× | 1.3×+1.0× | 0.6×+0.2× | 0.8×+0.7× | |
| Price / book | 2.7×+0.4× | 1.9×+0.6× | 3.5×+2.2× | 1.8×0.0× | 2.7×+2.3× | |
| EV / EBITDA | 3.1×+0.1× | 2.7×+0.5× | 4.5×+1.4× | 2×-40.0× | 3.4×— |
FAQ
- What are Nutex Health Inc.'s profit margins?
- Nutex Health Inc. (NUTX) runs a 51.3% gross margin and a 43.0% operating margin, with a 21.2% net margin.
- Where do Nutex Health Inc.'s ratios come from?
- Every ratio is computed from Nutex Health Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
